Institute for Research in Biomedicine
Melanoma is the most lethal skin cancer, and its incidence, though low, has steadily increased over the last few years. During melanoma progression, tumor cells spread across the body via
Recent years have generated considerable demand for information and interaction between Science and society. In this sense, the open day organized in the new Bios+ building in Bellinzona by IRB,
Secretory Immunoglobulin A (SIgA) is the antibody produced within mucosal membranes and is the most abundant antibody type synthesized in our body. In the intestine, SIgA possesses two antithetic functions
Ticino is becoming a biotech hub Greater Zurich Area April 1, 2021 Ricerca biomedica senza frontiere Ticino Management April, 2021 Immunoncologia, alleanza vincente Ticino Management May, 2021 Schierati con il
October 7, 2022: Virginia Crivelli won the “Best Poster” Price at the USI BioMed PhD Day with the poster “Human neutralizing antibodies to SARS-CoV-2 mutational coldspots that broadly crossreact with
September 8-11, 2022: Joint meeting of the Swiss Society for Allergology and Immunology (SSAI) and the International Immunocompromised Host Society (ICHS) at the Congress Center in Basel, Switzerland. Jonathan Muri
The Foundation for the Institute for Research in Biomedicine (IRB), and the entire IRB community, bid farewell to Countess Heidi Goëss-Horten, who passed away on June 12, 2022, and express
June 14, 2022: In the Symposia, an uninterrupted series of annual meetings focused on hot topics of cancer science, young investigators are encouraged to present their data in the poster session
The IRB informs that any press release mentioning the IRB should be reviewed by our media and communication service. Please contact:
Andrea Nava
andrea.nava@irb.usi.ch
+41 58 666 7250
Facebook / Twitter
